×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
18:00
HRD, mutation BRCA : impact sur les décisions chirurgicales
Pr Fabrice Lécuru
 
18:20
Chimiothérapie ? Anti-angiogénique ? PARPi ? Quand et pour qui ?
Dr Manuel Rodrigues

18:40

La survie s’améliore. Et la qualité de vie ?
Pr Florence Joly

19:00 Débat/discussion - Réponses aux questions

 
Réunion modérée par Pr Fabrice Lécuru

Shooting date : 2021-02-10
Last update : 2022-02-14
1 comment
Join the Discussion
  • Lauriane G. Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Wednesday, April 9th 2025 from 01pm to 01:45pm (GMT+2)
    Honolulu : Wednesday, April 9th 2025 from 02am to 02:45am (GMT+2)
    San Francisco : Wednesday, April 9th 2025 from 05am to 05:45am (GMT+2)
    New York : Wednesday, April 9th 2025 from 08am to 08:45am (GMT+2)
    Buenos Aires : Wednesday, April 9th 2025 from 09am to 09:45am (GMT+2)
    Reykjavik : Wednesday, April 9th 2025 from 12pm to 12:45pm (GMT+2)
    London / Dublin : Wednesday, April 9th 2025 from 01pm to 01:45pm (GMT+2)
    Paris / Berlin : Wednesday, April 9th 2025 from 02pm to 02:45pm (GMT+2)
    Istanbul : Wednesday, April 9th 2025 from 03pm to 03:45pm (GMT+2)
    Moscou / Dubaï : Wednesday, April 9th 2025 from 04pm to 04:45pm (GMT+2)
    Bangkok : Wednesday, April 9th 2025 from 07pm to 07:45pm (GMT+2)
    Shanghai : Wednesday, April 9th 2025 from 08pm to 08:45pm (GMT+2)
    Tokyo : Wednesday, April 9th 2025 from 09pm to 09:45pm (GMT+2)
    Sydney : Wednesday, April 9th 2025 from 11pm to 11:45pm (GMT+2)
    Wellington : Thursday, April 10th 2025 from 01am to 01:45am (GMT+2)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l’endomètre avancé pMMR P53 muté (épisode 3)

    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Honolulu : Tuesday, April 29th 2025 from 02am to 02:45am (GMT+2)
    San Francisco : Tuesday, April 29th 2025 from 05am to 05:45am (GMT+2)
    New York : Tuesday, April 29th 2025 from 08am to 08:45am (GMT+2)
    Buenos Aires : Tuesday, April 29th 2025 from 09am to 09:45am (GMT+2)
    Reykjavik : Tuesday, April 29th 2025 from 12pm to 12:45pm (GMT+2)
    London / Dublin : Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Paris / Berlin : Tuesday, April 29th 2025 from 02pm to 02:45pm (GMT+2)
    Istanbul : Tuesday, April 29th 2025 from 03pm to 03:45pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 29th 2025 from 04pm to 04:45pm (GMT+2)
    Bangkok : Tuesday, April 29th 2025 from 07pm to 07:45pm (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 08pm to 08:45pm (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 09pm to 09:45pm (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 11pm to 11:45pm (GMT+2)
    Wellington : Wednesday, April 30th 2025 from 01am to 01:45am (GMT+2)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l’endomètre avancé pMMR NSMP (épisode 4)

    Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Honolulu : Wednesday, May 18th 2022 from 07:30am to 09am (GMT+2)
    San Francisco : Wednesday, May 18th 2022 from 10:30am to 12pm (GMT+2)
    New York : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
    Buenos Aires : Wednesday, May 18th 2022 from 02:30pm to 04pm (GMT+2)
    Reykjavik : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
    London / Dublin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Paris / Berlin : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
    Istanbul : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 18th 2022 from 09:30pm to 11pm (GMT+2)
    Bangkok : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
    Shanghai : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
    Tokyo : Thursday, May 19th 2022 from 02:30am to 04am (GMT+2)
    Sydney : Thursday, May 19th 2022 from 04:30am to 06am (GMT+2)
    Wellington : Thursday, May 19th 2022 from 06:30am to 08am (GMT+2)

    Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

    Share
    Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 19th 2023 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, September 19th 2023 from 10am to 11:30am (GMT+2)
    New York : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, September 19th 2023 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 19th 2023 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, September 20th 2023 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, September 20th 2023 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, September 20th 2023 from 06am to 07:30am (GMT+2)

    Prise en charge des carcinomes séreux de bas grade en 2023

    Share
    Scroll Up